Clinical Trials Logo

Epicondylitis, Lateral clinical trials

View clinical trials related to Epicondylitis, Lateral.

Filter by:
  • None
  • Page 1

NCT ID: NCT06442618 Recruiting - Tennis Elbow Clinical Trials

Effectiveness of Extracorporeal Shockwave Therapy and Nutraceutical Supplementation in the Treatment of Epicondylitis: a Clinical Trial

Start date: March 1, 2024
Phase: N/A
Study type: Interventional

Lateral epicondylitis is a pathologic condition of the musculotendinous system, characterized by the presence of pain at the lateral epicondyle of the humerus; it is a tendinopathy of the extensor muscles of the forearm, often caused by overuse or repetitive use of the arm, forced extension of the elbow, or direct trauma to the humeral epicondyle. This study evaluated the efficacy of Extracorporeal ShockWave Treatment (ESWT) combined with a supplemental nutraceutical treatment of Hyaluronic Acid, Collagen, Vitamin C, and Manganese, compared with single treatment in patients with lateral epicondylitis in term of improvement in pain, functional capacity, muscle strength, and reduction of inflammation on ultrasound images. A clinical trial was conducted at the U.O.C. of "Recovery and Functional Rehabilitation" of A.O.U.P. "P. Giaccone" of Palermo from Marc 2024 to July 2024. Patients were randomized into 3 groups: in group "A", n° 5 sessions of focal ESWT were given every six days; in group "B", patients took daily for 30 days, supplemental nutraceutical treatment of Hyaluronic Acid, Collagen, Vitamin C, and Manganese; and group "C", patients had combined treatment of ESWT (one session every six days for a total of five sessions) and nutraceutical supplementation (one administration per day for one month). All patients were evaluated at enrollment (T0), after one month, at the end of rehabilitation treatment (T1), and at a follow up 30 days after the end of treatment (T2). Researched will compare patients treated with ESWT or with nutraceutical treatment, and patients who had combined treatment to see if there are real differences in term of pain reduction and improved short- and long-term quality of life.

NCT ID: NCT06160011 Completed - Clinical trials for Epicondylitis, Lateral

Epicondylar Muscle Activation in Tennis Players

Start date: December 1, 2023
Phase: N/A
Study type: Interventional

Epicondylitis is one of the most common pathologies in tennis players. The search for an effective treatment is necessary for the relief of symptoms and the return to sports practice. Therefore, a ddry needling treatment in combination with electricity is postulated as an alternative to isolated dry needling treatment or conventional physiotherapy treatment. Data will be collected in relation to pain and muscle activation by EMG in order to check the effectiveness of these techniques as well as the muscle activation that is generated.

NCT ID: NCT05238090 Not yet recruiting - Epicondylitis Clinical Trials

Efficacy of a Stretching Protocol for Lateral Epicondylitis

Start date: March 30, 2022
Phase: N/A
Study type: Interventional

Evaluation of the applying a stretching protocol to lateral epicondylitis.

NCT ID: NCT04875338 Completed - Clinical trials for Epicondylitis, Lateral

Injection in the Treatment of Lateral Epicondylitis. Randomized Controlled Trial

Start date: January 1, 2021
Phase: Phase 3
Study type: Interventional

The aim of the study is to compare the effectiveness of injection techniques in the treatment of elbow lateral epicondylitis. The functional and pain levels of the patients will be evaluated with scores such as DASH, VAS, PRTEE. At the same time, USG imaging will be evaluated before injection and in the third month after injection. The study was planned as a randomized controlled prospective study.

NCT ID: NCT04194710 Recruiting - Clinical trials for Epicondylitis, Lateral

Arthroscopic Debridement Versus Autologous Cytokine Rich Serum for the Treatment of Lateral Epicondylitis

DA-SARC
Start date: December 22, 2020
Phase: N/A
Study type: Interventional

This study aims to compare arthroscopic resection (surgical intervention) versus infiltration of cytokine rich serum (CRS) (proteins derived from the patient's own blood) for the treatment of lateral epicondylitis (LE).

NCT ID: NCT04026191 Completed - Clinical trials for Epicondylitis, Lateral

OVT for Epicondylosis (Tennis Elbow)

Start date: July 19, 2019
Phase: N/A
Study type: Interventional

To assess the residual risk of OrthoVisc-T (OVT) for the treatment of chronic lateral epicondylosis (Tennis Elbow). This trial will provide clinical data on a subject population not previously researched which have failed prior treatments for lateral epicondylosis.